Benzinga's Top Upgrades
Credit Suisse upgraded SPX Corporation (NYSE: SPXC) from Neutral to Outperform. The target price for SPX has been raised from $13 to $17. SPX shares closed at $14.09 on Thursday.
JP Morgan upgraded HB Fuller Co (NYSE: FUL) from Neutral to Overweight. The target price for H.B. Fuller has been raised from $37 to $46. H.B. Fuller shares closed at $40.79 on Thursday.
Goldman Sachs upgraded KBR, Inc. (NYSE: KBR) from Sell to Neutral. The target price for KBR has been raised from $12 to $16. KBR shares closed at $15.01 on Thursday.
Analysts at BMO Capital upgraded Hanover Insurance Group Inc (NYSE: THG) from Market Perform to Outperform. The target price for Hanover Insurance has been raised from $86 to $98. Hanover Insurance shares closed at $85.73 on Thursday.
Analysts at Scotia Howard Weil upgraded Nabors Industries Ltd. (NYSE: NBR) from Sector Perform to Sector Outperform. Nabors Industries shares closed at $8.69 on Thursday.
Analysts at BB&T Capital upgraded Eagle Materials, Inc. (NYSE: EXP) from Hold to Buy. Eagle Materials shares closed at $68.03 on Thursday.
Analysts at Monness Crespi Hardt upgraded Finish Line Inc (NASDAQ: FINL) from Neutral to Buy. Finish Line shares closed at $19.07 on Thursday.
Analysts at Raymond James upgraded Union Bankshares Corp (NASDAQ: UBSH) from Market Perform to Strong Buy. Union Bankshares shares closed at $23.11 on Thursday.
Analysts at SunTrust Robinson Humphrey upgraded PRA Health Sciences Inc (NASDAQ: PRAH) from Neutral to Buy. The target price for PRA Health Sciences has been raised from $47 to $51. PRA Health Sciences shares closed at $41.01 on Thursday.
Analysts at Scotia Howard Weil upgraded McDermott International (NYSE: MDR) from Sector Perform to Sector Outperform. McDermott shares closed at $3.97 on Thursday.
Latest Ratings for SPXC
Date | Firm | Action | From | To |
---|---|---|---|---|
Sep 2020 | William Blair | Upgrades | Market Perform | Outperform |
May 2020 | UBS | Maintains | Buy | |
May 2020 | Oppenheimer | Maintains | Outperform |
View More Analyst Ratings for SPXC
View the Latest Analyst Ratings
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: top upgradesUpgrades Analyst Ratings